Gerry Hanna Spotlights Editorial on Reframing Radiotherapy in Radiation Oncology
Gerry Hanna, Marie Curie Chair of Clinical Oncology at Trinity College Dublin, shared a post on X about a paper by Drew Moghanaki et al. published in the International Journal of Radiation Oncology, Biology and Physics:
“Key editorial just out in the International Journal of Radiation Oncology, Biology and Physics, led by Drew Moghanaki.
Throws down gauntlet Radiation Oncology community to reclaim the narrative around radiotherapy descriptors.
We must dispel the myths regarding RT, reassure patients, and ensure all eligible patients are offered treatment.”
Castalia Fernández, Radiation Oncologist at GenesisCare, shared this post, adding:
“Tomorrow, September 7, 2025, we celebrate for the first time Radiotherapy Awareness Day! This editorial in IJROBP, led by Drew Moghanaki, challenges the Radiation Oncology community to reclaim the narrative about radiotherapy: dispel myths about its ‘toxicity,’ reduce public fear, and ensure that all eligible patients receive treatment.”
Title: Missing the Target: Radiation, “Toxicity,” and Public Fear
Authors: Drew Moghanaki, Sue S. Yom, Neha Vapiwala
You can read the Full Article in the International Journal of Radiation Oncology, Biology and Physics.
More posts featuring Gerry Hanna.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023